| abstract |
The present invention relates to the use of a compound for the manufacture of a medicament for the treatment of a patient suffering from a disorder of the central nervous system associated with the 5-HT 1A receptor subtype. Wherein the carbon-carbon bond between the 3- and 4-positions of the carbostyril skeleton is a single bond or a double bond) or a salt thereof; and a pharmaceutically acceptable salt or solvate as an active ingredient. For drugs. |